Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Adenine derivatives










Image Number 5 for United States Patent #7521454.

This invention relates to an adenine derivative, a tautomer thereof, or a pharmaceutically acceptable salt thereof represented by general formula (I): ##STR00001## wherein X represents NR.sup.3 (wherein R.sup.3 represents a hydrogen atom or C.sub.1-3 alkyl) or the like; R.sup.1 represents substituted or unsubstituted alkyl or the like; R.sup.2 represents hydroxyl or the like; and Y represents a substituted or unsubstituted aromatic hetero ring or the like. Also, the present invention relates to pharmaceuticals such as an interferon inducer, antiviral agent, anticancer agent, type 2 helper T cell selective immune response inhibitor, antiallergic agent, and immune response modulator comprising the above derivative as an active ingredient.








 
 
  Recently Added Patents
Modular CID assembly for a lithium ion battery
Messaging service using different text messaging channels
Peptide epitopes of apolipoprotein B
Method and apparatus for a small power source for an implantable device
Hybrid device having a personal digital key and receiver-decoder circuit and methods of use
Devices, systems, and methods for separation of feedstock components
Mobile phone with transitional graphical user interface
  Randomly Featured Patents
Wet type electrophotography apparatus to heat toner on intermediate transfer medium
Wavelength selective element, manufacturing apparatus for manufacturing wavelength selective element, manufacturing method for manufacturing wavelength selective element, light source device,
Pipe blocking technique
Calibration methods for placement machines incorporating on-head linescan sensing
Low mercury, high discharge rate electrochemical cell
Apparatus for manufacturing vanadium pentoxide
Automatic call distribution center with queue position restoration for call-back customers
Backlight assembly and display device having the same
Polymer blends having reverse phase morphology for controlled delivery of bioactive agents
Method of cleaning using azeotrope-like compositions of 1,1-dichloro-1-fluoroethane, methanol and nitromethane